CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
 
   Industry Healthcare Facilities
   Sector  Healthcare
 

CLDS's EPS Net Growth by Quarter and Year

Us-china Biomedical Technology,'s EPS Net results by quarter and year




CLDS EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter February - -0.01 - 0.09
III Quarter November - -0.01 - -
II Quarter August -0.01 -0.02 - -
I Quarter May -0.02 - - -
FY   -0.03 -0.04 - 0.09



CLDS EPS Net second quarter 2019 Y/Y Growth Comment
Us-china Biomedical Technology, Inc. in the second quarter recorded EPS net loss of $ -0.01 .

According to the results reported in the second quarter, Us-china Biomedical Technology, Inc. achieved the best EPS Net growth in Healthcare Facilities industry. While Us-china Biomedical Technology, Inc.' s EPS Net no change of % ranks overall at the positon no. in the second quarter.




CLDS EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY   - - - -

Financial Statements
Us-china Biomedical Technology,'s second quarter 2019 EPS Net $ -0.01 CLDS's Income Statement
Us-china Biomedical Technology,'s second quarter 2018 EPS Net $ -0.02 Quarterly CLDS's Income Statement
New: More CLDS's historic EPS Net Growth >>


CLDS EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter February - - - -
III Quarter November - - - -
II Quarter August - - - -
I Quarter May - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019
You need to upgrade your Flash Player

Us-china Biomedical Technology,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's II. Quarter Q/Q EPS Net Comment
Despite the fact, that Us-china Biomedical Technology, Inc. in the II. Quarter 2019 revealed EPS net loss of $ -0.01 , some analyst mentioned, that those numbers point to improvement in contrast to the -0.02 in the first quarter.

Within Healthcare Facilities industry Us-china Biomedical Technology, Inc. achieved highest sequential EPS Net growth. While Us-china Biomedical Technology,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's II. Quarter Q/Q EPS Net Comment
Even if Us-china Biomedical Technology, Inc. in the II. Quarter 2019 showed EPS net loss of $ -0.01 , some analyst said, that this point to improvement relative to the -0.02 in the first quarter.

Within Healthcare Facilities industry Us-china Biomedical Technology, Inc. achieved highest sequential EPS Net growth. While Us-china Biomedical Technology,'s EPS Net growth quarter on quarter, overall rank is .


Us-china Biomedical Technology,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Aug 31 2018)
12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
12 Months Ending
(Nov 30 2017)
12 Months Ending
(Aug 31 2017)
Cumulative EPS Net 12 Months Ending $ -0.05 $ -0.06 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Us-china Biomedical Technology, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -0 in the Aug 31 2018 period.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Us-china Biomedical Technology, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -0 in the Aug 31 2018 period.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other EPS Net Growth
Healthcare Facilities Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
CLDS's EPS Net Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for CLDS's Competitors
EPS Net Growth for Us-china Biomedical Technology,'s Suppliers
EPS Net Growth for CLDS's Customers

You may also want to know
CLDS's Annual Growth Rates CLDS's Profitability Ratios CLDS's Asset Turnover Ratio CLDS's Dividend Growth
CLDS's Roe CLDS's Valuation Ratios CLDS's Financial Strength Ratios CLDS's Dividend Payout Ratio
CLDS's Roa CLDS's Inventory Turnover Ratio CLDS's Growth Rates CLDS's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Aug 31 2018 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Aug 31 2018
Neogen Corp -6.45 %$ -6.452 
Cryo Cell International Inc -62.50 %$ -62.500 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HVBC's Profile

Stock Price

HVBC's Financials

Business Description

Fundamentals

Charts & Quotes

HVBC's News

Suppliers

HVBC's Competitors

Customers & Markets

Economic Indicators

HVBC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071